Abstract:Importanceβ-Adrenergic stimulation elicits heart palpitations and dyspnea, key features of acute anxiety and sympathetic arousal, yet no neuroimaging studies have examined how the pharmacologic modulation of interoceptive signals is associated with fear-related neurocircuitry in individuals with generalized anxiety disorder (GAD).ObjectiveTo examine the neural circuitry underlying autonomic arousal induced via isoproterenol, a rapidly acting, peripheral β-adrenergic agonist akin to adrenaline.Design, Setting, and ParticipantsThis crossover randomized clinical trial of 58 women with artifact-free data was conducted from January 1, 2017, to November 31, 2019, at the Laureate Institute for Brain Research in Tulsa, Oklahoma.ExposuresFunctional magnetic resonance imaging was used to assess neural responses during randomized intravenous bolus infusions of isoproterenol (0.5 and 2.0 μg) and saline, each administered twice in a double-blind fashion.Main Outcomes and MeasuresBlood oxygen level–dependent responses across the whole brain during isoproterenol administration in patients with GAD vs healthy comparators. Cardiac and respiratory responses, as well as interoceptive awareness and anxiety, were also measured during the infusion protocol.ResultsOf the 58 female study participants, 29 had GAD (mean [SD] age, 26.9 [6.8] years) and 29 were matched healthy comparators (mean [SD] age, 24.4 [5.0] years). During the 0.5-μg dose of isoproterenol, the GAD group exhibited higher heart rate responses (b = 5.34; 95% CI, 2.06-8.61;P = .002), higher intensity ratings of cardiorespiratory sensations (b = 8.38; 95% CI, 2.05-14.71;P = .01), higher levels of self-reported anxiety (b = 1.04; 95% CI, 0.33-1.76;P = .005), and significant hypoactivation in the ventromedial prefrontal cortex (vmPFC) that was evident throughout peak response (Cohend = 1.55;P < .001) and early recovery (Cohend = 1.52;P < .001) periods. Correlational analysis of physiological and subjective indexes and percentage of signal change extracted during the 0.5-μg dose revealed that vmPFC hypoactivation was inversely correlated with heart rate (r56 = −0.51, adjustedP = .001) and retrospective intensity of both heartbeat (r56 = −0.50, adjustedP = .002) and breathing (r56 = −0.44, adjustedP = .01) sensations. Ventromedial prefrontal cortex hypoactivation correlated inversely with continuous dial ratings at a trend level (r56 = −0.38, adjustedP = .051), whereas anxiety (r56 = −0.28, adjustedP = .27) and chronotropic dose 25 (r56 = −0.14, adjustedP = .72) showed no such association.Conclusions and RelevanceIn this crossover randomized clinical trial, women with GAD exhibited autonomic hypersensitivity during low levels of adrenergic stimulation characterized by elevated heart rate, heightened interoceptive awareness, increased anxiety, and a blunted neural response localized to the vmPFC. These findings support the notion that autonomic hyperarousal may be associated with regulatory dysfunctions in the vmPFC, which could serve as a treatment target to help patients with GAD more appropriately appraise and regulate signals of sympathetic arousal.Trial RegistrationClinicalTrials.gov Identifier:NCT02615119

Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography study

Functional Brain Imaging Study in Patients with Anxiety Disorders Using SPECT

White Matter Integrity Alterations in First Episode, Treatment-Naive Generalized Anxiety Disorder

Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation

Heartbeat-evoked neural response abnormalities in generalized anxiety disorder during peripheral adrenergic stimulation

Abnormal Regional Activity in the Prefrontal-Limbic Circuit at Rest: Potential Imaging Markers and Treatment Predictors in Drug-Naive Anxiety Disorders.

Shared and distinctive neural substrates of generalized anxiety disorder with or without depressive symptoms and their roles in prognostic prediction

Attenuated responses to emotional expressions in women with generalized anxiety disorder

The Dysfunction of Right Prefrontal, Hippocampus and Cerebellum in Generalized Anxiety Disorder: a Visual Task Functional Magnetic Resonance Imaging Study

Dorsomedial Frontal Cortical Metabolic Differences of Comorbid Generalized Anxiety Disorder in Refractory Major Depression: A [18F] FDG PET Brain Imaging Study.

[Evaluation of 99Mtc-Ecd SPECT/CT Brain Imaging with Scenium Analysis in Patients with Generalized Anxiety Disorder].

Neurostructural abnormalities associated with axes of emotion dysregulation in generalized anxiety

Clonidine-induced Changes in the Spectral Distribution of Heart Rate Variability Correlate with Performance on a Test of Sustained Attention

Characteristics of cardio-Cerebrovascular modulation in patients with generalized anxiety disorder: an observational study

[Prefrontal and Superior Temporal Lobe Hyperactivity As a Biological Substrate of Generalized Anxiety Disorders].

Dysfunction of Resting-State Functional Connectivity of Amygdala Subregions in Drug-Naïve Patients With Generalized Anxiety Disorder

Identifying Generalized Anxiety Disorder Using Resting State Habenular Circuitry

Altered heartbeat perception sensitivity associated with brain structural alterations in generalised anxiety disorder

Emotion reactivity-related brain network analysis in generalized anxiety disorder: a task fMRI study

Differential Effects of Clonidine, Haloperidol, Diazepam and Tryptophan Depletion on Focused Attention and Attentional Search

Alternations in Cortical Thickness and Functional Connectivity in Patients with Generalized Anxiety Disorder